Back to search

Boston University

Unlocking macrophage engineering and therapies with synthetic polarization circuits

Abstract

dc:description.abstract

Macrophages are versatile immune cells capable of diverse functions, enabled by unique cellular properties such as inflammation scavenging, phagocytosis capability, and perhaps most interesting, their unparallel phenotype plasticity. In response to extracellular signals, macrophages activate distinctive functional programs and differentiate into two general subtypes: classically activated macrophages (M1) and alternatively activated macrophages (M2). M1 macrophages promote inflammation and show anti-tumor activity in synergy with T cells, while M2 macrophages play a vital role in wound healing and treating anti-inflammatory diseases. While macrophage phenotypic plasticity is essential for maintaining tissue homeostasis, in pathological contexts such as cancer, microenvironmental signals often skew macrophages towards phenotypes that exacerbate disease progression. Therefore, the ability to precisely control macrophage activation states in vivo could unlock new therapeutic strategies to restore immune function and halt disease mechanisms.To leverage the diverse immune functions of macrophages—in both immune environments and pathological contexts, we developed a synthetic system for inducible macrophages polarization combining three synergistic innovations: (1) engineered STAT effector proteins that can robustly drive constitutive and sustained macrophage polarization to M1 or M2 state, independent of cytokine induction. (2) synZiFTRs 2.0, an optimized human gene regulation toolkit built upon our previous work, enabling drug-inducible and enhanced transgene expression with minimal basal activity; and (3) monocyte-targeting nanoparticles for cell-specific delivery of synZiFTR induction agents. Central to this advance is the discovery of the IWS1 TIMs domain as a potent transcriptional synergizer, which enhances human transcriptional activators like p65 through stimulating transcriptional elongation, without compromising safety or inducibility. This work establishes a generalizable framework for macrophage reprogramming with spatiotemporal precision, offering a tunable and clinically translatable approach for diverse applications. By decoupling polarization cues from local signals and integrating polarization effectors with synthetic gene regulation switches, our platform allows robust macrophage polarization against microenvironmental inferences while minimizing off-target effects. These advances not only provide new tools for macrophage-based therapies but also illuminate broader principles for engineering immune cell behavior in therapeutic contexts.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Biomedical Engineering
Grantor
Boston University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ye, Hanrong (Belle)
Advisors dc:contributor.advisor
  • Khalil, Ahmad S.
  • Wong, Joyce Y.
ORCID dc:identifier.orcid

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/50592

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Ye, Hanrong (Belle). Unlocking macrophage engineering and therapies with synthetic polarization circuits. doctoral thesis, Boston University, 2025. https://hdl.handle.net/2144/50592